Caribou Biosciences, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-44.0% -$138M
$175M
Current Assets↓-33.8% -$74M
$145M
Cash & Equivalents↓-24.1% -$4M
$12M
ST Investments
—
Receivables↓-74.0% -$196K
$69K
Net PPE↓-64.9% -$13M
$7M
Total Liabilities↓-11.9% -$7M
$53M
Current Liabilities↓-17.1% -$5M
$25M
Account Payables↑+133.6% +$3M
$6M
Stockholders Equity↓-51.7% -$131M
$122M
Retained Earnings↓-33.0% -$148M
$-597M
Operating Lease ROU Asset↓-11.7% -$2M
$18M
Operating Lease Liability↑+8.6% +$2M
$27M
Gross PP&E↓-36.9% -$12M
$20M
Accumulated Depreciation↑+5.0% +$642K
$14M
Contract Asset↓-13.1% -$152K
$1M
Contract Liability↓-43.4% -$3M
$4M
Contract Liability (Current)↓-39.4% -$1M
$2M
Contract Liability (Noncurrent)↓-47.2% -$2M
$2M
Remaining Performance Obligation↓-43.8% -$3M
$4M